THC250117P230000
- 0.00
- 0.000.00%
Tenet Healthcare Newsroom
Tenet Healthcare Is Maintained at Buy by Truist Securities
Tenet Healthcare Price Target Cut to $175.00/Share From $190.00 by Truist Securities
Tenet Healthcare Analyst Ratings
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Cuts Target Price to $175
BofA Securities Maintains Tenet Healthcare(THC.US) With Buy Rating
JP Morgan Assumes Tenet Healthcare at Overweight, Announces Price Target of $175
Universal Health, Tenet Downgraded at Goldman Sachs
Tenet Healthcare Cut to Neutral From Buy by Goldman Sachs
Tenet Healthcare Analyst Ratings
Goldman Sachs Downgrades Tenet Healthcare(THC.US) to Hold Rating, Cuts Target Price to $140
Tenet Healthcare (THC) Was Downgraded to a Hold Rating at Wells Fargo
J.P. Morgan Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $175
Tenet Healthcare Cut to Equal-Weight From Overweight by Wells Fargo
Wells Fargo Downgrades Tenet Healthcare(THC.US) to Hold Rating, Cuts Target Price to $150
Tenet Healthcare Analyst Ratings
Raymond James Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $195
Jefferies Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $200
Tenet Healthcare (THC) Receives a Buy From Jefferies
Barclays Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $190
Barclays Reaffirms Their Buy Rating on Tenet Healthcare (THC)